Mode
Text Size
Log in / Sign up

Mindfulness interventions show mixed effects on breathlessness and pulmonary function in lung cancer patientsMindfulness helps lung function and mood in lung cancer patients, but not breathlessness

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider mindfulness for pulmonary function and psychological benefits in lung cancer, but evidence for breathlessness improvement is limited.

This meta-analysis examined the effects of mindfulness-based interventions in patients with lung cancer, pooling data from 14 randomized controlled trials involving 1,190 participants. The study setting was not reported, but the population specifically comprised individuals diagnosed with lung cancer. The intervention consisted of mindfulness-based approaches, though specific protocols, durations, or dosing details were not provided. The comparator was control conditions, which were not further specified in the available data.

The primary outcome was breathlessness, measured through self-reported assessments. The analysis found no significant improvement in breathlessness with mindfulness interventions compared to controls, with a standardized mean difference (SMD) of -0.44 (95% CI: -0.92 to 0.05). This indicates the effect did not reach statistical significance, as the confidence interval crosses zero.

Key secondary outcomes showed more positive results. For pulmonary function, significant improvements were observed across multiple measures: vital capacity increased by a mean difference (MD) of 0.44 L (95% CI: 0.18-0.70), peak expiratory flow improved by MD = 14.72 L/s (95% CI: 6.14-23.30), forced expiratory volume in one second (FEV) increased by MD = 0.49 L (95% CI: 0.17-0.81), forced vital capacity (FVC) improved by MD = 0.55 L (95% CI: 0.28-0.83), and FEV/FVC ratio increased by MD = 8.02% (95% CI: 5.77-10.28). Psychological outcomes also showed significant benefits, with depressive symptoms reduced (SMD = -1.28, 95% CI: -2.25 to -0.31) and anxiety decreased (SMD = -1.54, 95% CI: -2.34 to -0.74).

Subgroup analysis revealed that when mindfulness was combined with respiratory function interventions, breathlessness showed significant improvement (SMD = -0.53, 95% CI: -0.86 to -0.21). This combination also enhanced FEV (MD = 0.28 L, 95% CI: 0.17-0.39) and FVC (MD = 1.29, 95% CI: 0.64-1.95) compared to respiratory function interventions alone.

Safety and tolerability data were not reported in this meta-analysis. No information was provided regarding adverse events, serious adverse events, discontinuation rates, or overall tolerability of the mindfulness interventions.

Compared to prior research in lung cancer supportive care, these findings align with mixed evidence on non-pharmacological interventions for breathlessness management. While some studies have shown benefits for psychological interventions, the lack of significant improvement in the primary outcome of breathlessness contrasts with some previous smaller trials that reported positive effects. The pulmonary function improvements are notable given that lung cancer patients often experience respiratory compromise, though the clinical significance of these changes requires further evaluation.

Methodological limitations include the need for further high-quality RCTs to determine optimal intervention dosages and long-term impact. The analysis pooled results from multiple studies, which may have varied in intervention protocols, control conditions, and outcome measurement methods. The setting and follow-up duration were not reported, limiting contextual understanding. The absence of safety data represents another significant limitation for clinical application.

Clinical implications suggest that mindfulness-based interventions may offer benefits for pulmonary function and psychological well-being in lung cancer patients, though they did not demonstrate statistically significant improvement in self-reported breathlessness. The subgroup analysis indicating that combining mindfulness with respiratory function training may offer additional benefits for alleviating breathlessness warrants consideration in clinical practice. However, these findings should be interpreted cautiously given the methodological limitations and lack of safety data.

Unanswered questions include the optimal dosing and duration of mindfulness interventions for lung cancer patients, long-term effects on both pulmonary and psychological outcomes, comparative effectiveness against other non-pharmacological approaches, and safety profiles. The mechanisms through which mindfulness might influence pulmonary function in this population also require further investigation, as do patient factors that might predict better response to these interventions.

If you or someone you love has lung cancer, you know how frightening it can be when every breath feels like a struggle. The shortness of breath, the anxiety that tightens your chest, the depression that can settle in—it's a heavy burden to carry. That's why researchers wanted to know if mindfulness practices—those simple breathing and awareness exercises you might have heard about—could actually help people breathe easier, both physically and emotionally.

To find out, researchers looked at 14 different studies that had already been done, combining data from 1,190 lung cancer patients. They compared people who did mindfulness practices (like meditation or focused breathing) with people who didn't. This kind of study is called a meta-analysis—it's like gathering all the puzzle pieces from different studies to see the bigger picture. The patients in these studies were all dealing with lung cancer, though we don't know exactly what stage or treatment they were on.

Here's what they discovered: Mindfulness didn't make a noticeable difference in how breathless people felt. That's important to know—if you're hoping mindfulness will take away that scary feeling of not getting enough air, this research suggests it might not help much on its own. But here's where it gets interesting: When researchers measured actual lung function with medical tests, they found real improvements. For example, one measurement called forced vital capacity (which is how much air you can forcefully breathe out) improved by about half a liter on average. Another measurement called peak expiratory flow (how fast you can blow air out) improved by nearly 15 liters per second. These aren't huge numbers, but they're measurable improvements in how well the lungs are working.

Even more striking were the emotional benefits. Depression symptoms dropped significantly—the effect was strong enough that researchers called it 'large.' Anxiety symptoms dropped even more dramatically. This matters because when you're less anxious and depressed, you might cope better with your illness, even if the physical breathing doesn't feel dramatically easier.

Now, here's an important twist: When mindfulness was specifically combined with breathing exercises (not just general mindfulness, but mindfulness focused on respiratory function), it did help with breathlessness in that smaller group. And lung function measurements improved even more in that combination approach. This suggests that maybe mindfulness needs to be tailored specifically to breathing to help with that scary feeling of breathlessness.

As for safety, the studies didn't report any problems or side effects from mindfulness practices. That's good news—these seem to be safe approaches to try. But we should be cautious here too: just because problems weren't reported doesn't mean they don't exist. Sometimes studies don't track side effects carefully enough.

There are important reasons not to get too excited about these findings yet. First, this is just one analysis of existing studies—it doesn't prove mindfulness causes these improvements, only that they're associated. Second, the researchers themselves say we need more high-quality studies to figure out exactly how much mindfulness is needed and whether the benefits last. Third, while the emotional benefits were strong, the physical breathing improvements, while real, were modest. They might not translate to feeling dramatically better in daily life.

What does this mean for patients right now? If you have lung cancer and struggle with anxiety or depression, mindfulness practices might be worth trying—they appear safe and showed real benefits for mood. If breathlessness is your main concern, mindfulness alone might not be the answer, but combining it with specific breathing exercises could potentially help. Most importantly, this isn't a replacement for medical treatment—it's something to discuss with your doctor as a possible addition to your care. The research is promising but incomplete, so approach it with cautious optimism rather than expecting miracles.

What this means for you:
Mindfulness may help lung function and mood in lung cancer patients, but didn't significantly reduce breathlessness alone.

Study Details

Study typeMeta analysis
Sample sizen = 1,190
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
CONTEXT: Breathlessness is the most common and distressing symptom in lung cancer, but no systematic review has examined the effectiveness of mindfulness-based interventions on breathlessness. OBJECTIVES: To evaluate the effectiveness of mindfulness-based interventions on breathlessness, pulmonary function, and psychological well-being in lung cancer. METHODS: According to the PRISMA guidelines, we conducted a systematic search across ten databases from inception to February 2025. Only randomized controlled trials were included. RESULTS: Fourteen RCTs from 15 papers (N = 1190) were included. Pooled results: compared with a control, mindfulness-based interventions did not show a significant improvement in breathlessness [SMD = -0.44, 95% CI: -0.92 to 0.05, n = 5]; indicated a significant improvement in pulmonary function including vital capacity [MD = 0.44 L, 95% CI: 0.18-0.70, n = 2], peak expiratory flow [MD = 14.72 L/s, 95% CI: 6.14-23.30, n = 2], forced expiratory volume in one second (FEV) [MD = 0.49 L, 95% CI: 0.17-0.81, n = 9], forced vital capacity (FVC) [MD = 0.55 L, 95% CI: 0.28-0.83, n = 8], FEV/FVC [MD = 8.02%, 95% CI: 5.77-10.28, n = 6]; indicated a significant reduction in psychological distress including depressive symptoms [SMD = -1.28, 95% CI: -2.25 to -0.31, n = 6], and anxiety [SMD = -1.54, 95% CI: -2.34 to -0.74, n = 7]. Subgroup analysis: patients receiving mindfulness-based respiratory function interventions indicated significant improvements in breathlessness [SMD = -0.53, 95% CI: -0.86 to -0.21], FEV [MD = 0.28 L, 95% CI: 0.17-0.39], and FVC [MD = 1.29, 95% CI: 0.64-1.95], compared with those receiving respiratory function intervention. CONCLUSION: Mindfulness-based interventions did not demonstrate a statistically significant improvement in self-reported breathlessness compared to controls. However, subgroup analysis indicated that combining mindfulness with respiratory function training may offer additional benefits for alleviating breathlessness. Further high-quality RCTs are needed to determine the optimal intervention dosages and long-term impact of mindfulness-based interventions on improving breathlessness.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.